White-Label Telehealth Alternatives Compared: Bask vs. OpenLoop vs. TEHR vs. Owning Your Stack

The best white-label telehealth alternatives — Bask Health, OpenLoop, SteadyMD, Wheel, TEHR, and MD Integrations — each solve a different piece of the operator puzzle, but all share the same structural problem: they own your patient data, pharmacy relationship, or prescriber network, which means they own your switching costs.

If you're evaluating platforms right now, that sentence is the thing this post is actually about.

---

Why This Comparison Exists

Most "telehealth platform comparison" content is written by the platforms themselves. It compares features, not ownership structures. It tells you who has a mobile app or a nicer intake form. It doesn't tell you what happens when you want to leave.

This post is written for operators — clinic founders, DTC Rx brand owners, anyone building a recurring-prescription business — who want to understand the landscape before they sign a contract. We're going to compare the major incumbents on the four axes that actually determine your leverage as a business:

1. Who owns the patient data?
2. Who owns the pharmacy contract?
3. Who owns the prescriber relationship?
4. What are the real switching costs?

We'll credit each platform where it's genuinely strong. We'll be specific about where it creates lock-in. And at the end, we'll map what "owning your own stack" actually requires, so you can compare apples to apples.

Nothing ships without a licensed provider in any of these architectures — that's a non-negotiable for compliant Rx telehealth, and any platform that obscures that fact is a red flag.

---

The Landscape at a Glance

Before the teardowns: a fast map of who is actually building what.

Platform	Core product	Shopify?	Pharmacy network	Capital raised
MD Integrations	Clinician network (50-state MD/DO)	Yes (Shopify App, May 2024)	Partner pharmacies (not owned)	$77M (Oct 2025)
Bask Health	All-in-one: EMR + eRx + storefront + pharmacy	Shopify-first	30+ compounders (own network)	~$760K seed
OpenLoop	Clinician network (50-state)	No native integration	No pharmacy rail	Undisclosed
SteadyMD	Clinician network + white-label telehealth	Partial	No pharmacy rail	~$77M total
Wheel	Clinician marketplace + platform	Partial	No pharmacy rail	~$200M+
TEHR	Turnkey DTC telehealth stack	No	Limited	Undisclosed
DrCare247	White-label telehealth software	No	No	Undisclosed

The table already reveals the first structural insight: most of what gets called a "white-label telehealth platform" is actually a clinician-network company with a compliance wrapper. Provider coverage and pharmacy fulfillment are two different problems. Most incumbents solve only one.

---

MD Integrations: The Best-Funded Threat, But It's Selling a Clinician Network

What it is. MD Integrations is the most-capitalized player in the Shopify-adjacent space: $77M raised in October 2025, an official Shopify App Store listing (launched May 2024), 200+ brands, and a verified 50-state MD/DO network. It has real compliance credentials — HIPAA, SOC2, LegitScript.

Where it's genuinely strong. If your core problem is "I need 50-state licensed physicians and I want a native Shopify integration," MD Integrations solves that faster than anyone else in the market. The onboarding story of ~7-day integration is credible for a mid-market operator.

The structural limitation. MD Integrations is a clinician company, not a pharmacy-routing company. It does not own pharmacies. It routes prescriptions to partner pharmacies. It does not offer a documented, public, multi-pharmacy orchestration layer that an operator can contract for independently of the clinician network.

If you want to bring your own clinicians — say, because you have your own licensed provider or a clinic relationship you've spent years building — MD Integrations may not sell you just the fulfillment rail. You're buying the clinicians, the platform, and their pharmacy partners as a bundle.

Ownership verdict.

• Patient data: inside MD Integrations' HIPAA environment.
• Pharmacy contract: via MD Integrations' partners, not yours directly.
• Prescriber relationship: MD Integrations' network.
• Switching costs: high. Your patient records, order history, and prescriber continuity all live in their system.

---

Bask Health: Closest to the Vision, Weakest Balance Sheet

What it is. Bask bills itself as "the Shopify for telehealth" and it's not wrong as positioning. Founded 2021. It offers an EMR, eRx, a no-code site builder, a Shopify-first posture, and access to 30+ compounding pharmacies including 503A and 503B facilities. Of the named incumbents, Bask has gone furthest toward building a true compounded-Rx brand infrastructure.

Where it's genuinely strong. The pharmacy network breadth is real. 30+ compounders with compounding capabilities — including 503B outsourcing facilities — gives a Bask operator more formulary flexibility than most platforms. The free Start-up tier lowers the bar to get started.

The structural limitation. Bask raised approximately $760K in seed funding. That's a small team operating an ambitious product. The API and webhooks — the features that would let you route externally, integrate your own systems, and truly own the technical layer — are paywalled to the top "Custom" tier, with sign-in-gated documentation. You can't pre-evaluate what you're actually building on.

More importantly: even on a paid tier, your pharmacy network is Bask's pharmacy network. When you sign with Bask, you're signing with their compounder contracts. If a specific pharmacy you need isn't in their network — or if their network relationship changes — that's your problem.

Ownership verdict.

• Patient data: inside Bask's environment.
• Pharmacy contract: Bask's partner network.
• Prescriber relationship: Bask-connected providers or your own (more flexible than some platforms).
• Switching costs: medium-to-high. The API accessibility on lower tiers makes data portability a real concern.

Related: Bask Health Alternatives: 6 Ways to Launch DTC Telehealth Without the All-in-One Lock-In

---

OpenLoop: A Clinician Network Wearing a Platform Hat

What it is. OpenLoop offers a 50-state clinician network with white-label telehealth software underneath. It's a legitimate option if your primary gap is provider coverage — licensed clinicians across all 50 states, already credentialed, available quickly.

The structural limitation. OpenLoop does not have a pharmacy fulfillment layer. It is not a pharmacy-routing company. If you are building a compounded-Rx brand — TRT, HRT, hair loss, ED, LDN, tretinoin, oral weight-loss alternatives — you still need to solve pharmacy independently after signing with OpenLoop. That's a second vendor relationship, a second integration, and two separate points of lock-in.

There's also a positioning issue for operators who want to keep patients in their own system: OpenLoop's network model means the prescriber relationship is with OpenLoop's clinician, not with a provider on your team. When a patient needs continuity of care, or when you want to renegotiate your provider arrangement, you're renegotiating with OpenLoop's network.

Ownership verdict.

• Patient data: split between OpenLoop and whatever pharmacy layer you build separately.
• Pharmacy contract: none — you source this yourself.
• Prescriber relationship: OpenLoop's clinician network.
• Switching costs: medium on the provider side, separate switching cost on pharmacy.

---

SteadyMD and Wheel: Enterprise-Grade, But Not Built for DTC Rx Operators

What they are. SteadyMD ($77M raised) and Wheel ($200M+ raised) are both clinician marketplace companies targeting larger enterprise telehealth and digital health customers. They supply credentialed, 50-state providers at scale. Both have legitimate compliance infrastructure.

The structural limitation. Neither SteadyMD nor Wheel has a compounding pharmacy fulfillment layer. They are not DTC Rx fulfillment companies — they're workforce-as-a-service businesses for telehealth. Their native customer is a health plan, a large employer, or an established digital health company, not a founder launching a 500-patient TRT or HRT brand.

The pricing and contract structures at SteadyMD and Wheel reflect their enterprise focus. Getting into a contract, getting onboarded, and getting to first prescription will take longer than the DTC alternatives. For most operators building in the $1M–$10M ARR range, these platforms are the wrong fit for the stage.

Ownership verdict.

• Patient data: complex — typically within each platform's environment.
• Pharmacy contract: none, you source separately.
• Prescriber relationship: their clinician network.
• Switching costs: high, due to contract structures and clinician credentialing.

---

TEHR: Low Cost, Grey-Market Risk

What it is. TEHR (and similar turnkey DTC stacks) positions as a low-cost, fast-to-launch option for telehealth brands. The price point is attractive. The barrier to entry is low.

The structural limitation. TEHR carries a grey-market reputation in operator communities, and that reputation is not accidental. The compliance posture — on LegitScript, on payment processing, on provider oversight documentation — is weaker than the other named players.

This matters materially. Visa and Mastercard both require active LegitScript Healthcare Merchant Certification to process payments for GLP-1, peptide, hormone, or compounded-Rx telehealth. Google and Meta require LegitScript to run paid ads in the same categories. A platform built without robust LegitScript compliance can pull down your entire CAC engine. You lose payment processing, you lose ads, you rebuild from zero.

There's also a provider-approval risk. In compliant Rx telehealth, nothing ships without a licensed provider's approval on every order. Platforms that speed past this step to reduce friction create real regulatory exposure for the operators using them.

Ownership verdict.

• Patient data: variable, depends on implementation.
• Pharmacy contract: limited.
• Prescriber relationship: limited.
• Switching costs: low dollar cost, but high compliance remediation cost if you built on a grey-market foundation.

---

DrCare247: International Focus, Wrong Architecture for US Compounded Rx

What it is. DrCare247 is a white-label telemedicine software company, primarily serving international markets and general telehealth use cases (video consults, general practice, urgent care). It is not built around the US compounded-Rx regulatory and pharmacy-integration stack.

For a US operator building a compounded TRT, HRT, or hair-loss brand with a Shopify storefront and a 503A pharmacy partner, DrCare247 is the wrong category of tool. It doesn't have the pharmacy API integrations, the HIPAA middleware designed for the US compounding stack, or the LegitScript-aligned compliance posture. It's in this comparison because it comes up in searches, not because it's a real competitive option for this buyer.

---

The Comparison Table Operators Actually Need

	Patient data ownership	Pharmacy contract	Prescriber relationship	Can you export and leave?
MD Integrations	Vendor	Vendor's partners	Vendor's network	Hard — data + Rx history lives in their system
Bask Health	Vendor	Vendor's network	Flexible (own or theirs)	Hard — API portability limited on lower tiers
OpenLoop	Split (vendor + separate pharmacy)	You source separately	Vendor's network	Medium on provider side
SteadyMD / Wheel	Vendor	You source separately	Vendor's network	Hard — enterprise contracts
TEHR	Vendor	Limited	Vendor	Easy — but you're starting over on compliance
Own Your Stack	You	You contract directly	Your provider or your network	You leave with everything

---

What "Owning Your Stack" Actually Requires

This isn't a theoretical argument. Here is what the own-your-stack architecture looks like in practice — and what it costs you in setup complexity versus what it gives you in leverage.

The three layers.

Your Shopify storefront handles catalog, cart, and checkout. It does not hold PHI. It does not process the Rx. Your HIPAA middleware — a compliant layer that lives between Shopify and the pharmacy — holds the patient record, manages the intake form, gates on provider approval, and routes the order to your pharmacy. Your pharmacy adapter connects to whichever compounders you've contracted with directly.

When an order comes in, the flow is: Shopify orders/paid webhook fires, your middleware captures intake and PHI, a licensed provider reviews and approves, the approval triggers the pharmacy route, the pharmacy ships, tracking writes back to Shopify and to your clinic dashboard. Orders out in under 60 seconds once approved. Provider approval on every single one.

What you own.

• The patient record lives in your HIPAA environment. You hold the chart, the Rx history, the contact data. If you switch pharmacies tomorrow, your patient data doesn't move — because it was never in the pharmacy's system.
• Your pharmacy contracts are direct. If a compounder raises prices, drops a formulary, or goes out of business, you route to the next pharmacy without rebuilding your storefront.
• Your prescriber relationships are yours. Whether you use your own licensed clinicians, a PC/MSO structure, or a contracted provider network, those relationships are your business asset.

What it costs you in setup.

• You need LegitScript certification from day one — this is a Day-0 requirement that gates both payment processing and paid ads. Budget $975 one-time plus approximately $2,150 per year per site, and 2–4 months of review time. This is not optional on any architecture; don't let a platform tell you they handle it and leave you exposed.
• You need a HIPAA-compliant middleware layer with BAAs executed against every pharmacy and every provider organization. This is the technical product that sits between Shopify and the pharmacy.
• You need a high-risk merchant account (Shopify Payments won't work for Rx; neither will standard Stripe). Budget 0.6–2.0% above standard rates for the third-party gateway surcharge.

The setup complexity is real. It's front-loaded. But you're building it once, and the resulting business is yours — patient data, pharmacy contracts, prescriber relationships, and all.

Related: Own Your Telehealth Stack: Escaping Platform Lock-In and Becoming Your Own System of Record

---

The Category Breadth Point

One more thing worth saying directly, because it gets glossed over in most platform comparisons: the formulary you build on matters as much as the platform you choose.

Every category has different regulatory posture, different compounding complexity, and different renewal economics:

• TRT / men's hormones — Schedule III, controlled-substance credentialing required, strong refill LTV
• HRT / menopause — cash-pay-heavy, compounded estradiol/progesterone, strong retention
• Hair loss — finasteride/minoxidil combinations, high attach rate, note the 2025 FDA safety alert on compounded topical finasteride
• ED / sexual health — compounded sildenafil/tadalafil, high cross-sell potential
• Tretinoin / skincare — easy attach SKU, not controlled, strong acquisition hook
• LDN / low-dose naltrexone — growing category, non-controlled, durable
• Oral weight-loss alternatives — metformin/naltrexone/topiramate combinations, the post-GLP-1 category pivot

We're not anchoring on GLP-1 compounding. You already know why: FDA's move to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list is directionally clear, and building a business on that molecule's compounding window is the wrong bet in mid-2026. The good news is that the formulary above is durable, recurring, and generates the multi-script attach economics that actually build a business.

Choose a platform — or build your own architecture — that can support all of these, not just one. Most platforms are built around the GLP-1 moment and are under-engineered for the formulary breadth that comes after it.

Related: Compounding Pharmacy Fulfillment for Telehealth: The Operator's Guide to Order Routing and the System of Record

---

The Verdict

There is no bad platform in this comparison. There are platforms built for different buyers at different stages.

If you need 50-state clinicians fast and you have a separate fulfillment solution, OpenLoop or SteadyMD gets you there. If you want the broadest compounding pharmacy access in an all-in-one wrapper and you're comfortable with a seed-stage vendor, Bask is the most honest version of the telehealth-in-a-box model. If you have the volume and capital to justify enterprise contract structures, MD Integrations has the Shopify integration, the capital behind it, and the credentialed clinician scale.

But if the question you're actually asking is "how do I build a telehealth business I actually own" — patient data, pharmacy relationships, prescriber continuity, and all — then none of these platforms are the answer. They solve the short-term problem and create the long-term one.

The own-your-stack path is more setup work. It's also the only architecture that leaves you in a position to scale, switch pharmacies, renegotiate provider rates, and exit at a multiple that reflects the business you built — not the platform you rented.

---

Ready to See What This Looks Like in Practice?

If you want to see what the own-your-stack architecture looks like for your specific clinic — Shopify storefront, licensed provider approval on every order, multi-pharmacy routing, orders out in under 60 seconds — talk to the neolife team. No deck, no pitch: a 30-minute working session on your formulary and clinic setup.

Talk to neolife